icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Daclatasvir (DCV; BMS-790052), an NS5A Replication Complex Inhibitor, in Combination With Peginterferon Alfa-2b and Ribavirin in Japanese Treatment-Na´ve and Nonresponder Patients With Chronic HCV Genotype 1 Infection
 
 
  Reported by Jules Levin
AASLD Nov 5-9 2011 SF
 
Suzuki F,1 Chayama K,2 Kawakami Y,2 Toyota J,3 Karino Y,3 Mochida S,4 Nagoshi S,4 Hayashi N,5 Takehara T,6 Ishikawa H,7 Miyagoshi H,7 Yang R,8 McPhee F,8 Hughes E,9 Kumada H1 1Toranomon Hospital, Tokyo, Japan; 2Hiroshima University, Hiroshima, Japan; 3Sapporo-Kousei General Hospital, Sapporo, Japan; 4Saitama Medical University, Saitama, Japan; 5Kansai-Rousai Hospital, Amagasaki, Japan; 6Osaka University, Osaka, Japan; 7Bristol-Myers KK, Tokyo, Japan; 8Bristol-Myers Squibb, Wallingford, CT; 9Bristol-Myers Squibb Research & Development, Princeton, NJ

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif